TL;DR
This paper introduces a novel wide-field electron arc technique using a scatterer to treat widespread Kaposi's sarcoma (KS) on the extremities. This method significantly reduces radiation dose to underlying healthy tissues compared to conventional photon techniques, offering a promising new option for patients, especially those with recurrent disease.
What Problem Does This Paper Address?
Kaposi's sarcoma (KS) often presents as widespread, superficial lesions on the extremities (hands and feet). While radiation therapy is effective, conventional megavoltage photon beams deliver dose not only to the tumor but also to deeper, healthy tissues like blood vessels and bone. This can lead to long-term complications such as fibrosis, edema, and joint contracture, especially problematic for patients requiring re-irradiation. Electron beam therapy is better suited for superficial targets, but achieving uniform dose distribution on curved or irregular surfaces like extremities has been challenging with standard techniques. This paper aims to address this by developing and clinically implementing a wide-field electron arc technique with a scatterer to improve dose sparing to normal tissues while effectively treating widespread KS on the extremities.
Methods
The core of this research is the development and evaluation of a novel wide-field electron arc technique with a scatterer. Here's a breakdown of the methodology:
- Monte Carlo (MC) Modeling: The researchers used the TOPAS (GEANT4-based) MC simulation platform to accurately model 4- and 6-MeV electron beams from a Varian Trilogy linear accelerator. This modeling was meticulously tuned to achieve less than 2% deviation from measured data for Percentage Depth Dose (PDD) and lateral profiles.
- Scatterer Integration: A key innovation is the use of a cylindrical acrylic scatterer (20 cm diameter, 5 mm thick). This scatterer is designed to spread the electron beam, creating a more uniform dose distribution on curved skin surfaces.
- Phantom Studies:
- Dosimetric Characterization: The MC models were validated using Gafchromic EBT3 films to measure radial and longitudinal dose profiles in an acrylic phantom.
- Phantom Study for Feasibility: A foot and leg phantom, mimicking lower extremities, was used to assess the technique's feasibility. MC simulations and dosimetry measurements (using MOSFETs) were performed to verify surface dose uniformity.
- Clinical Implementation and Comparison:
- Patient Case: The technique was applied to a patient with recurrent KS on the lower extremities who had previously received photon therapy.
- Treatment Planning: For this patient, 4- and 6-MeV electron arc plans were created. These were then compared against two conventional photon-based plans:
- Two opposite photon beams.
- Volumetric Modulated Arc Therapy (VMAT) with a bolus.
- Comparison Metrics: Dosimetric parameters such as dose to the Planning Target Volume (PTV), dose to Organs at Risk (OARs), conformity index (CI), and homogeneity index (HI) were analyzed for all four plans.
Datasets
The study utilized a combination of simulated data and experimental measurements:
- Monte Carlo Simulations: Extensive MC simulations were performed using the TOPAS platform to model electron beam characteristics and dose distributions.
- Experimental Measurements:
- Ionization Chamber Measurements: Used for initial validation of MC models (PDD and lateral profiles).
- Gafchromic EBT3 Films: Employed for measuring radial and longitudinal dose profiles in phantom studies.
- MOSFET Dosimeters: Used for in-vivo surface dose measurements on a phantom.
- OSLD Dosimeters: Utilized for in-vivo dosimetry during the clinical treatment of the patient.
- Patient CT Images: Acquired for treatment planning of the individual patient.
- Phantom Data: Data from a foot and leg mimicking phantom was used for feasibility studies.
No new benchmark datasets were introduced; rather, the study focused on validating its technique against established methods using standard phantom setups and patient data.
Key Insights and Ideas
- Scatterer as a Game-Changer for Superficial Electron Therapy: The integration of a simple acrylic scatterer fundamentally changes the dose distribution of electron beams, allowing for more uniform coverage on curved surfaces. This overcomes a major limitation of conventional electron therapy for extremities.
- Significant Dose Sparing to Deep Tissues: The electron arc technique with a scatterer demonstrably delivers substantially less radiation dose to underlying normal tissues (bones, soft tissues) compared to photon-based treatments. This is crucial for minimizing long-term side effects, especially in re-irradiation scenarios.
- Trade-off Between Coverage/Homogeneity and Dose Sparing: While the electron arc technique excels at dose sparing, it comes with a slight compromise in PTV coverage and dose homogeneity compared to photon techniques. This highlights a critical clinical decision point: balancing optimal tumor coverage with minimizing normal tissue toxicity.
- Clinical Viability for Recurrent Disease: The successful implementation in a patient with recurrent KS, who had previously been treated with photons, underscores the technique's potential as a valuable option for challenging cases where re-irradiation is necessary and dose to previously irradiated areas must be minimized.
- Improved Treatment Convenience: The scatterer-based electron arc technique offers potential advantages in treatment setup and reproducibility compared to photon techniques that often require complex bolus arrangements.
Key Results
- MC Model Accuracy: The MC models achieved excellent agreement with measurements, with deviations typically less than 2% for PDD and lateral profiles.
- Dose Saving: The electron arc plans resulted in significantly lower mean doses to OARs (soft tissue and bones) compared to both two-opposite photon and VMAT plans. For example, the mean dose to soft tissue was as low as 7.05 Gy for the 4-MeV electron arc plan, compared to 21.94 Gy for VMAT.
- PTV Coverage and Homogeneity: The electron arc plans showed inferior PTV coverage and homogeneity compared to photon techniques. The homogeneity index (HI) was higher (indicating less homogeneity), and the conformity index (CI) was lower for the electron arc plans.
- Clinical Application: The technique was successfully applied to a patient with widespread KS, demonstrating its clinical feasibility. In-vivo dosimetry confirmed that the surface dose was within 10% of the prescribed dose, with minor deviations near the extremities (toe and heel) due to proximity to the scatterer.
Limitations and Future Work
- PTV Coverage and Homogeneity: The authors acknowledge that the electron arc technique with a scatterer shows inferior coverage and homogeneity for the PTV compared to photon techniques. This is a key trade-off that needs careful consideration in treatment planning.
- Dose Decrease Near Scatterer: A limitation identified is that the radiation dose decreases near the inner surface of the scatterer. This phenomenon, due to electron energy loss, can make uniform dose delivery to the treatment lesion difficult. The authors suggest mitigating this by using low-density immobilizers to create a small separation (0.5-2.5 cm) between the skin target and the scatterer's inner surface.
- Field Size Considerations: The paper emphasizes that the field size must be sufficiently large to cover the scatterer to ensure uniform dose distribution, especially for irregular or larger lesions.
- Future Work: The study suggests that this technique could be useful for treating other multifocal skin diseases and highlights its particular benefit for patients who have received prior radiotherapy, where minimizing re-irradiation dose to normal tissues is paramount. Further optimization of scatterer materials and geometry could potentially improve dose homogeneity.
Summary updated